HEADER HYDROLASE/HYDROLASE INHIBITOR 19-OCT-04 1W9U TITLE SPECIFICITY AND AFFNITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR TITLE 2 ARGADIN AGAINST ASPERGILLUS FUMIGATUS CHITINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.1.14; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ARGADIN; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ASPERGILLUS FUMIGATUS; SOURCE 3 ORGANISM_TAXID: 746128; SOURCE 4 ATCC: 13073; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX6P; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: CLONOSTACHYS; SOURCE 13 ORGANISM_TAXID: 110564 KEYWDS CHITINASE, ARGADIN, CYCLOPENTAPEPTIDE INHIBITORS, CHITINASE KEYWDS 2 INHIBITORS, GLYCOSIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON,D.J.ADAMS, AUTHOR 2 K.SHIOMI,S.OMURA,D.M.F.VAN AALTEN REVDAT 9 13-DEC-23 1W9U 1 REMARK REVDAT 8 15-NOV-23 1W9U 1 REMARK LINK ATOM REVDAT 7 24-APR-19 1W9U 1 REMARK SEQRES LINK REVDAT 6 05-AUG-15 1W9U 1 TITLE SOURCE REMARK SEQRES REVDAT 6 2 1 HET HETNAM FORMUL LINK REVDAT 6 3 1 HETATM ATOM CONECT REVDAT 5 09-APR-14 1W9U 1 REMARK REVDAT 4 13-JUL-11 1W9U 1 VERSN REVDAT 3 24-FEB-09 1W9U 1 VERSN REVDAT 2 29-JUN-05 1W9U 1 JRNL REVDAT 1 17-NOV-04 1W9U 0 JRNL AUTH F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON, JRNL AUTH 2 D.J.ADAMS,K.SHIOMI,S.OMURA,D.M.F.VAN AALTEN JRNL TITL SPECIFICITY AND AFFINITY OF NATURAL PRODUCT JRNL TITL 2 CYCLOPENTAPEPTIDE INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, JRNL TITL 3 HUMAN AND BACTERIAL CHITINASES JRNL REF CHEM.BIOL. V. 12 65 2005 JRNL REFN ISSN 1074-5521 JRNL PMID 15664516 JRNL DOI 10.1016/J.CHEMBIOL.2004.10.013 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1999208.620 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 115692 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 0.800 REMARK 3 FREE R VALUE TEST SET COUNT : 932 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 19068 REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE : 0.2560 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 0.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 172 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6237 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 1284 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.23000 REMARK 3 B22 (A**2) : 0.23000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.510 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.410 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.280 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 47.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ARGADIN.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : ARGADIN.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1W9U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1290021344. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 113.0 REMARK 200 PH : 9.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979488 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 116077 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1D2K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M LI2SO4 0.1 M TRIS PH 9.5, PH REMARK 280 9.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.87600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.93800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 74.81400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ARGADIN IS CYCLIC PEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ARGADIN REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ARG A 2 REMARK 465 PHE A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 SER A 6 REMARK 465 THR A 7 REMARK 465 ILE A 8 REMARK 465 VAL A 9 REMARK 465 LYS A 10 REMARK 465 VAL A 11 REMARK 465 ALA A 12 REMARK 465 LEU A 13 REMARK 465 LEU A 14 REMARK 465 LEU A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 LEU A 18 REMARK 465 CYS A 19 REMARK 465 VAL A 20 REMARK 465 ASP A 21 REMARK 465 ALA A 22 REMARK 465 ALA A 23 REMARK 465 VAL A 24 REMARK 465 MET A 25 REMARK 465 TRP A 26 REMARK 465 ASN A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 THR A 30 REMARK 465 SER A 31 REMARK 465 SER A 32 REMARK 465 THR A 33 REMARK 465 ASP A 34 REMARK 465 LEU A 35 REMARK 465 GLU A 36 REMARK 465 ALA A 37 REMARK 465 ARG A 38 REMARK 465 MET B 1 REMARK 465 ARG B 2 REMARK 465 PHE B 3 REMARK 465 ALA B 4 REMARK 465 THR B 5 REMARK 465 SER B 6 REMARK 465 THR B 7 REMARK 465 ILE B 8 REMARK 465 VAL B 9 REMARK 465 LYS B 10 REMARK 465 VAL B 11 REMARK 465 ALA B 12 REMARK 465 LEU B 13 REMARK 465 LEU B 14 REMARK 465 LEU B 15 REMARK 465 SER B 16 REMARK 465 SER B 17 REMARK 465 LEU B 18 REMARK 465 CYS B 19 REMARK 465 VAL B 20 REMARK 465 ASP B 21 REMARK 465 ALA B 22 REMARK 465 ALA B 23 REMARK 465 VAL B 24 REMARK 465 MET B 25 REMARK 465 TRP B 26 REMARK 465 ASN B 27 REMARK 465 ARG B 28 REMARK 465 ASP B 29 REMARK 465 THR B 30 REMARK 465 SER B 31 REMARK 465 SER B 32 REMARK 465 THR B 33 REMARK 465 ASP B 34 REMARK 465 LEU B 35 REMARK 465 GLU B 36 REMARK 465 ALA B 37 REMARK 465 ARG B 38 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR B 433 CA C O CB OG1 CG2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS B 158 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 55 -111.42 -87.89 REMARK 500 ASP A 90 88.32 -153.40 REMARK 500 TYR A 112 -129.95 -126.08 REMARK 500 ALA A 259 26.75 -149.33 REMARK 500 ASN A 267 65.92 -159.65 REMARK 500 GLN A 318 -159.42 -86.74 REMARK 500 TYR B 55 -114.74 -89.91 REMARK 500 TYR B 112 -135.68 -126.74 REMARK 500 ALA B 259 25.12 -148.10 REMARK 500 ASN B 267 64.40 -154.00 REMARK 500 GLN B 318 -154.44 -89.75 REMARK 500 HSE C1436 -106.08 -160.68 REMARK 500 HSE D1436 -108.36 -167.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2044 DISTANCE = 6.48 ANGSTROMS REMARK 525 HOH A2052 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH A2125 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A2132 DISTANCE = 6.10 ANGSTROMS REMARK 525 HOH A2220 DISTANCE = 6.27 ANGSTROMS REMARK 525 HOH B2074 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH B2112 DISTANCE = 6.53 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 10-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 11-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 9-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 10-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1439 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1440 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1441 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1442 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1438 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1439 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1440 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ARGADIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF ARGADIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1W9P RELATED DB: PDB REMARK 900 SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE REMARK 900 INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, HUMAN AND BACTERIAL REMARK 900 CHITINASE REMARK 900 RELATED ID: 1W9V RELATED DB: PDB REMARK 900 SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE REMARK 900 ARGIFIN AGAINST ASPERGILLUS FUMIGATUS DBREF 1W9U A 1 433 UNP Q873X9 Q873X9 1 433 DBREF 1W9U B 1 433 UNP Q873X9 Q873X9 1 433 DBREF 1W9U C 1434 1438 PDB 1W9U 1W9U 1434 1438 DBREF 1W9U D 1434 1438 PDB 1W9U 1W9U 1434 1438 SEQRES 1 A 433 MET ARG PHE ALA THR SER THR ILE VAL LYS VAL ALA LEU SEQRES 2 A 433 LEU LEU SER SER LEU CYS VAL ASP ALA ALA VAL MET TRP SEQRES 3 A 433 ASN ARG ASP THR SER SER THR ASP LEU GLU ALA ARG ALA SEQRES 4 A 433 SER SER GLY TYR ARG SER VAL VAL TYR PHE VAL ASN TRP SEQRES 5 A 433 ALA ILE TYR GLY ARG ASN HIS ASN PRO GLN ASP LEU PRO SEQRES 6 A 433 VAL GLU ARG LEU THR HIS VAL LEU TYR ALA PHE ALA ASN SEQRES 7 A 433 VAL ARG PRO GLU THR GLY GLU VAL TYR MET THR ASP SER SEQRES 8 A 433 TRP ALA ASP ILE GLU LYS HIS TYR PRO GLY ASP SER TRP SEQRES 9 A 433 SER ASP THR GLY ASN ASN VAL TYR GLY CYS ILE LYS GLN SEQRES 10 A 433 LEU TYR LEU LEU LYS LYS GLN ASN ARG ASN LEU LYS VAL SEQRES 11 A 433 LEU LEU SER ILE GLY GLY TRP THR TYR SER PRO ASN PHE SEQRES 12 A 433 ALA PRO ALA ALA SER THR ASP ALA GLY ARG LYS ASN PHE SEQRES 13 A 433 ALA LYS THR ALA VAL LYS LEU LEU GLN ASP LEU GLY PHE SEQRES 14 A 433 ASP GLY LEU ASP ILE ASP TRP GLU TYR PRO GLU ASN ASP SEQRES 15 A 433 GLN GLN ALA ASN ASP PHE VAL LEU LEU LEU LYS GLU VAL SEQRES 16 A 433 ARG THR ALA LEU ASP SER TYR SER ALA ALA ASN ALA GLY SEQRES 17 A 433 GLY GLN HIS PHE LEU LEU THR VAL ALA SER PRO ALA GLY SEQRES 18 A 433 PRO ASP LYS ILE LYS VAL LEU HIS LEU LYS ASP MET ASP SEQRES 19 A 433 GLN GLN LEU ASP PHE TRP ASN LEU MET ALA TYR ASP TYR SEQRES 20 A 433 ALA GLY SER PHE SER SER LEU SER GLY HIS GLN ALA ASN SEQRES 21 A 433 VAL TYR ASN ASP THR SER ASN PRO LEU SER THR PRO PHE SEQRES 22 A 433 ASN THR GLN THR ALA LEU ASP LEU TYR ARG ALA GLY GLY SEQRES 23 A 433 VAL PRO ALA ASN LYS ILE VAL LEU GLY MET PRO LEU TYR SEQRES 24 A 433 GLY ARG SER PHE ALA ASN THR ASP GLY PRO GLY LYS PRO SEQRES 25 A 433 TYR ASN GLY VAL GLY GLN GLY SER TRP GLU ASN GLY VAL SEQRES 26 A 433 TRP ASP TYR LYS ALA LEU PRO GLN ALA GLY ALA THR GLU SEQRES 27 A 433 HIS VAL LEU PRO ASP ILE MET ALA SER TYR SER TYR ASP SEQRES 28 A 433 ALA THR ASN LYS PHE LEU ILE SER TYR ASP ASN PRO GLN SEQRES 29 A 433 VAL ALA ASN LEU LYS SER GLY TYR ILE LYS SER LEU GLY SEQRES 30 A 433 LEU GLY GLY ALA MET TRP TRP ASP SER SER SER ASP LYS SEQRES 31 A 433 THR GLY SER ASP SER LEU ILE THR THR VAL VAL ASN ALA SEQRES 32 A 433 LEU GLY GLY THR GLY VAL PHE GLU GLN SER GLN ASN GLU SEQRES 33 A 433 LEU ASP TYR PRO VAL SER GLN TYR ASP ASN LEU ARG ASN SEQRES 34 A 433 GLY MET GLN THR SEQRES 1 B 433 MET ARG PHE ALA THR SER THR ILE VAL LYS VAL ALA LEU SEQRES 2 B 433 LEU LEU SER SER LEU CYS VAL ASP ALA ALA VAL MET TRP SEQRES 3 B 433 ASN ARG ASP THR SER SER THR ASP LEU GLU ALA ARG ALA SEQRES 4 B 433 SER SER GLY TYR ARG SER VAL VAL TYR PHE VAL ASN TRP SEQRES 5 B 433 ALA ILE TYR GLY ARG ASN HIS ASN PRO GLN ASP LEU PRO SEQRES 6 B 433 VAL GLU ARG LEU THR HIS VAL LEU TYR ALA PHE ALA ASN SEQRES 7 B 433 VAL ARG PRO GLU THR GLY GLU VAL TYR MET THR ASP SER SEQRES 8 B 433 TRP ALA ASP ILE GLU LYS HIS TYR PRO GLY ASP SER TRP SEQRES 9 B 433 SER ASP THR GLY ASN ASN VAL TYR GLY CYS ILE LYS GLN SEQRES 10 B 433 LEU TYR LEU LEU LYS LYS GLN ASN ARG ASN LEU LYS VAL SEQRES 11 B 433 LEU LEU SER ILE GLY GLY TRP THR TYR SER PRO ASN PHE SEQRES 12 B 433 ALA PRO ALA ALA SER THR ASP ALA GLY ARG LYS ASN PHE SEQRES 13 B 433 ALA LYS THR ALA VAL LYS LEU LEU GLN ASP LEU GLY PHE SEQRES 14 B 433 ASP GLY LEU ASP ILE ASP TRP GLU TYR PRO GLU ASN ASP SEQRES 15 B 433 GLN GLN ALA ASN ASP PHE VAL LEU LEU LEU LYS GLU VAL SEQRES 16 B 433 ARG THR ALA LEU ASP SER TYR SER ALA ALA ASN ALA GLY SEQRES 17 B 433 GLY GLN HIS PHE LEU LEU THR VAL ALA SER PRO ALA GLY SEQRES 18 B 433 PRO ASP LYS ILE LYS VAL LEU HIS LEU LYS ASP MET ASP SEQRES 19 B 433 GLN GLN LEU ASP PHE TRP ASN LEU MET ALA TYR ASP TYR SEQRES 20 B 433 ALA GLY SER PHE SER SER LEU SER GLY HIS GLN ALA ASN SEQRES 21 B 433 VAL TYR ASN ASP THR SER ASN PRO LEU SER THR PRO PHE SEQRES 22 B 433 ASN THR GLN THR ALA LEU ASP LEU TYR ARG ALA GLY GLY SEQRES 23 B 433 VAL PRO ALA ASN LYS ILE VAL LEU GLY MET PRO LEU TYR SEQRES 24 B 433 GLY ARG SER PHE ALA ASN THR ASP GLY PRO GLY LYS PRO SEQRES 25 B 433 TYR ASN GLY VAL GLY GLN GLY SER TRP GLU ASN GLY VAL SEQRES 26 B 433 TRP ASP TYR LYS ALA LEU PRO GLN ALA GLY ALA THR GLU SEQRES 27 B 433 HIS VAL LEU PRO ASP ILE MET ALA SER TYR SER TYR ASP SEQRES 28 B 433 ALA THR ASN LYS PHE LEU ILE SER TYR ASP ASN PRO GLN SEQRES 29 B 433 VAL ALA ASN LEU LYS SER GLY TYR ILE LYS SER LEU GLY SEQRES 30 B 433 LEU GLY GLY ALA MET TRP TRP ASP SER SER SER ASP LYS SEQRES 31 B 433 THR GLY SER ASP SER LEU ILE THR THR VAL VAL ASN ALA SEQRES 32 B 433 LEU GLY GLY THR GLY VAL PHE GLU GLN SER GLN ASN GLU SEQRES 33 B 433 LEU ASP TYR PRO VAL SER GLN TYR ASP ASN LEU ARG ASN SEQRES 34 B 433 GLY MET GLN THR SEQRES 1 C 5 0AR DPR HSE HIS UN1 SEQRES 1 D 5 0AR DPR HSE HIS UN1 MODRES 1W9U 0AR C 1434 ARG MODRES 1W9U HSE C 1436 SER L-HOMOSERINE MODRES 1W9U 0AR D 1434 ARG MODRES 1W9U HSE D 1436 SER L-HOMOSERINE HET 0AR C1434 14 HET DPR C1435 7 HET HSE C1436 7 HET UN1 C1438 10 HET 0AR D1434 14 HET DPR D1435 7 HET HSE D1436 7 HET UN1 D1438 10 HET SO4 A1439 5 HET SO4 A1440 5 HET SO4 A1441 5 HET SO4 A1442 5 HET SO4 B1438 5 HET SO4 B1439 5 HET SO4 B1440 5 HETNAM 0AR N-[N-[(4S)-4-AZANYL-5-HYDROXY-5-OXO- HETNAM 2 0AR PENTYL]CARBAMIMIDOYL]ETHANAMIDE HETNAM DPR D-PROLINE HETNAM HSE L-HOMOSERINE HETNAM UN1 2-AMINOHEXANEDIOIC ACID HETNAM SO4 SULFATE ION FORMUL 3 0AR 2(C8 H16 N4 O3) FORMUL 3 DPR 2(C5 H9 N O2) FORMUL 3 HSE 2(C4 H9 N O3) FORMUL 3 UN1 2(C6 H11 N O4) FORMUL 5 SO4 7(O4 S 2-) FORMUL 12 HOH *1284(H2 O) HELIX 1 1 TRP A 52 TYR A 55 5 4 HELIX 2 2 ASN A 60 LEU A 64 5 5 HELIX 3 3 PRO A 65 LEU A 69 5 5 HELIX 4 4 ASP A 90 GLU A 96 1 7 HELIX 5 5 TYR A 112 ASN A 125 1 14 HELIX 6 6 TYR A 139 PRO A 141 5 3 HELIX 7 7 ASN A 142 SER A 148 1 7 HELIX 8 8 THR A 149 GLY A 168 1 20 HELIX 9 9 ASN A 181 ALA A 207 1 27 HELIX 10 10 GLY A 221 LEU A 228 1 8 HELIX 11 11 HIS A 229 GLN A 235 1 7 HELIX 12 12 ASN A 267 THR A 271 5 5 HELIX 13 13 ASN A 274 GLY A 285 1 12 HELIX 14 14 PRO A 288 ASN A 290 5 3 HELIX 15 15 LYS A 329 LEU A 331 5 3 HELIX 16 16 PRO A 342 MET A 345 5 4 HELIX 17 17 ASN A 362 GLY A 377 1 16 HELIX 18 18 ASP A 385 ASP A 389 5 5 HELIX 19 19 THR A 391 ASP A 394 5 4 HELIX 20 20 SER A 395 LEU A 404 1 10 HELIX 21 21 GLY A 406 VAL A 409 5 4 HELIX 22 22 TYR A 424 ASN A 429 1 6 HELIX 23 23 TRP B 52 TYR B 55 5 4 HELIX 24 24 ASN B 60 LEU B 64 5 5 HELIX 25 25 PRO B 65 LEU B 69 5 5 HELIX 26 26 ASP B 90 ILE B 95 1 6 HELIX 27 27 TYR B 112 ASN B 125 1 14 HELIX 28 28 TYR B 139 PRO B 141 5 3 HELIX 29 29 ASN B 142 SER B 148 1 7 HELIX 30 30 THR B 149 GLY B 168 1 20 HELIX 31 31 ASN B 181 ALA B 207 1 27 HELIX 32 32 GLY B 221 LEU B 228 1 8 HELIX 33 33 HIS B 229 GLN B 235 1 7 HELIX 34 34 ASN B 267 THR B 271 5 5 HELIX 35 35 ASN B 274 GLY B 285 1 12 HELIX 36 36 PRO B 288 ASN B 290 5 3 HELIX 37 37 LYS B 329 LEU B 331 5 3 HELIX 38 38 PRO B 342 MET B 345 5 4 HELIX 39 39 ASN B 362 GLY B 377 1 16 HELIX 40 40 ASP B 385 ASP B 389 5 5 HELIX 41 41 THR B 391 ASP B 394 5 4 HELIX 42 42 SER B 395 GLY B 405 1 11 HELIX 43 43 GLY B 406 VAL B 409 5 4 HELIX 44 44 TYR B 424 ASN B 429 1 6 SHEET 1 AA11 ARG A 44 VAL A 50 0 SHEET 2 AA11 GLY A 380 TRP A 384 1 O ALA A 381 N VAL A 46 SHEET 3 AA11 ILE A 292 PRO A 297 1 O LEU A 294 N MET A 382 SHEET 4 AA11 PHE A 239 LEU A 242 1 O TRP A 240 N VAL A 293 SHEET 5 AA11 LEU A 213 SER A 218 1 O VAL A 216 N ASN A 241 SHEET 6 AA11 GLY A 171 ASP A 175 1 O LEU A 172 N THR A 215 SHEET 7 AA11 LYS A 129 GLY A 135 1 O LEU A 132 N ASP A 173 SHEET 8 AA11 HIS A 71 VAL A 79 1 O VAL A 72 N LEU A 131 SHEET 9 AA11 ARG A 44 VAL A 50 1 O VAL A 47 N LEU A 73 SHEET 10 AA11 GLY A 380 TRP A 384 1 O ALA A 381 N VAL A 46 SHEET 11 AA11 ARG A 44 VAL A 50 1 O ARG A 44 N ALA A 381 SHEET 1 AB 5 VAL A 325 ASP A 327 0 SHEET 2 AB 5 TYR A 299 PHE A 303 -1 O GLY A 300 N TRP A 326 SHEET 3 AB 5 PHE A 356 SER A 359 -1 O LEU A 357 N PHE A 303 SHEET 4 AB 5 ALA A 346 ASP A 351 -1 O SER A 349 N ILE A 358 SHEET 5 AB 5 THR A 337 LEU A 341 -1 O THR A 337 N TYR A 350 SHEET 1 BA10 ARG B 44 VAL B 50 0 SHEET 2 BA10 GLY B 380 TRP B 384 1 O ALA B 381 N VAL B 46 SHEET 3 BA10 ILE B 292 PRO B 297 1 O LEU B 294 N MET B 382 SHEET 4 BA10 PHE B 239 LEU B 242 1 O TRP B 240 N VAL B 293 SHEET 5 BA10 LEU B 213 SER B 218 1 O VAL B 216 N ASN B 241 SHEET 6 BA10 GLY B 171 ASP B 175 1 O LEU B 172 N THR B 215 SHEET 7 BA10 LYS B 129 GLY B 135 1 O LEU B 132 N ASP B 173 SHEET 8 BA10 HIS B 71 VAL B 79 1 O VAL B 72 N LEU B 131 SHEET 9 BA10 ARG B 44 VAL B 50 1 O VAL B 47 N LEU B 73 SHEET 10 BA10 ARG B 44 VAL B 50 1 N VAL B 50 O TYR B 48 SHEET 1 BB 5 VAL B 325 ASP B 327 0 SHEET 2 BB 5 TYR B 299 PHE B 303 -1 O GLY B 300 N TRP B 326 SHEET 3 BB 5 PHE B 356 SER B 359 -1 O LEU B 357 N PHE B 303 SHEET 4 BB 5 ALA B 346 ASP B 351 -1 O SER B 349 N ILE B 358 SHEET 5 BB 5 THR B 337 LEU B 341 -1 O THR B 337 N TYR B 350 LINK C 0AR C1434 N DPR C1435 1555 1555 1.33 LINK N 0AR C1434 C UN1 C1438 1555 1555 1.33 LINK C DPR C1435 N HSE C1436 1555 1555 1.33 LINK C HSE C1436 N HIS C1437 1555 1555 1.33 LINK C4 HSE C1436 N HIS C1437 1555 1555 1.47 LINK C HIS C1437 N UN1 C1438 1555 1555 1.33 LINK C 0AR D1434 N DPR D1435 1555 1555 1.33 LINK N 0AR D1434 C UN1 D1438 1555 1555 1.33 LINK C DPR D1435 N HSE D1436 1555 1555 1.33 LINK C4 HSE D1436 N HIS D1437 1555 1555 1.47 LINK C HSE D1436 N HIS D1437 1555 1555 1.33 LINK C HIS D1437 N UN1 D1438 1555 1555 1.33 CISPEP 1 ALA A 75 PHE A 76 0 -4.12 CISPEP 2 GLU A 177 TYR A 178 0 -1.64 CISPEP 3 LEU A 331 PRO A 332 0 0.11 CISPEP 4 TRP A 384 ASP A 385 0 -4.04 CISPEP 5 ALA B 75 PHE B 76 0 -3.80 CISPEP 6 GLU B 177 TYR B 178 0 -1.62 CISPEP 7 LEU B 331 PRO B 332 0 -0.19 CISPEP 8 TRP B 384 ASP B 385 0 -5.33 SITE 1 AC1 6 HIS A 229 LEU A 230 LYS A 231 ASP A 232 SITE 2 AC1 6 HOH A2403 HOH A2675 SITE 1 AC2 4 ASN A 181 ASP A 182 HOH A2676 HOH A2677 SITE 1 AC3 5 THR A 149 ASP A 150 HOH A2678 HOH A2679 SITE 2 AC3 5 HOH A2680 SITE 1 AC4 7 HOH A2161 HOH A2681 HOH A2682 HOH A2683 SITE 2 AC4 7 ARG B 283 ALA B 289 HOH B2396 SITE 1 AC5 6 SER B 148 THR B 149 ASP B 150 HOH B2595 SITE 2 AC5 6 HOH B2596 HOH B2597 SITE 1 AC6 6 HIS B 229 LEU B 230 LYS B 231 ASP B 232 SITE 2 AC6 6 HOH B2598 HOH B2599 SITE 1 AC7 4 ASN B 181 ASP B 182 HOH B2600 HOH B2601 SITE 1 AC8 18 TYR A 48 TRP A 137 ASP A 175 GLU A 177 SITE 2 AC8 18 TYR A 245 ASP A 246 PHE A 251 TYR A 299 SITE 3 AC8 18 ARG A 301 VAL A 325 TRP A 384 HOH C2667 SITE 4 AC8 18 HOH C2669 HOH C2670 HOH C2671 HOH C2672 SITE 5 AC8 18 HOH C2673 HOH C2674 SITE 1 AC9 18 TYR B 48 TRP B 137 ASP B 175 GLU B 177 SITE 2 AC9 18 TYR B 245 ASP B 246 PHE B 251 TYR B 299 SITE 3 AC9 18 ARG B 301 GLU B 322 VAL B 325 TRP B 384 SITE 4 AC9 18 HOH B2341 HOH D2585 HOH D2586 HOH D2589 SITE 5 AC9 18 HOH D2591 HOH D2592 CRYST1 117.752 117.752 99.752 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008492 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008492 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010025 0.00000